Capricor Therapeutics, Inc. (CAPR)
29.69
-0.21
(-0.70%)
USD |
NASDAQ |
Mar 26, 12:08
Capricor Therapeutics Cash from Investing (Quarterly) : 43.09M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -0.0582M |
| Vaxart, Inc. | 1.989M |
| Allogene Therapeutics, Inc. | 33.61M |
| REGENXBIO, Inc. | 37.54M |
| Replimune Group, Inc. | 75.12M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.57M |
| Cash from Financing (Quarterly) | 248.82M |
| Free Cash Flow | -81.54M |
| Free Cash Flow Per Share (Quarterly) | -0.5873 |
| Free Cash Flow to Equity (Quarterly) | -28.72M |
| Free Cash Flow to Firm (Quarterly) | -25.65M |
| Free Cash Flow Yield | -5.91% |